SectorLife Science Tools and Services
Established Date--
Listing Date13/04/2017
ExchangeNASDAQ Stock Exchange
Full-time Employees14
Fiscal Year Ends31/12
Security TypeCommon stock
Office address3060 Pegasus Park Drive, Building 6, Dallas, Texas 75247
Business
IntroductionForte Biosciences, Inc., is a clinical-stage dermatological company dedicated to the development of living biotherapies FB-401 for the treatment of inflammatory skin diseases. FB-401 has completed phase 1/2 a testing in adults and children (3 years and older) with atopic dermatitis. There is a substantial demand for safe and effective therapies, especially for patients with pediatric atopic dermatitis. Forte plans to advance FB-401 into Phase 2 clinical trials in the mid 2020s.
